ALB and tuberculosis: Additionally, clinical parameters including AST, ALB, and Tbil measured within seven days after treatment initiation (baseline) were significantly greater in TB patients with ATDILI than that in those with non-ATDILI (P < 0.021, P=<0.001, P < 0.004, respectively).